Porvair Sciences new Krystal™ Glass Bottom microplate with Schott D 263® M technology provides unmatched performance for whole-plate CCD imaging and laser detection applications. Krystal™ Glass Bottom plates combine the advantageous optical properties of glass, low background and low birefringence, with the versatility of a microplate. Constructed in ultra-pure grade borosilicate glass – the new D 263® M, Krystal™ Glass Bottom microplate is precision manufactured for high optical performance in high resolution microscopy applications. These glass bottom plates offer high optical quality, thermal stability, chemical resistance, and low autofluorescence to suit a wide range of samples for accurate and reliable light and fluorescence readings. Due to the high clarity bottom of Schott D 263® M glass, exact positioning of the microplate on microscopes and imaging apparatus can be made with ease. The latest Krystal™ microplate is available in different thicknesses: 50 µm, 175 µm and in addition, a high-performance version D 263® M / 1.5H plate with a thickness tolerance of +/- 5 µm is also available for high sensitivity applications. Precisely manufactured to SBS / ANSI microplate dimensions the affordable Krystal™ Glass Bottom design is fully compatible with all commercially available plate readers, robotic sample processors and automated liquid handling systems. The complete Krystal™ range of glass bottom microplates is available tissue culture treated to optimise cell growth or without surface modification. The Porvair Sciences Krystal™ glass bottom plate range demonstrate higher performance than standard polystyrene plates for fluorescence assays, luminescence detection, scintillation counting and high-resolution microscopy using confocal imaging. For further information on Krystal™ Glass Bottom microplates please visit https://www.microplates.com/krystal-clear-bottom-opaque-sides/ or contact Porvair Sciences Ltd on +44 1978 666222 / +1 800 552 3696 / int.sales@porvairsciences.com Established in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates, top quality microplate equipment, and sample preparation technologies for analytical sciences. Throughout North America, Porvair Sciences products are available and locally supported from sister company, JG Finneran Associates Inc., which also designs, manufactures, and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates, and closures. Porvair Sciences and JG Finneran is a wholly owned subsidiary of Porvair plc. * D 263® M is a registered trademark of SCHOTT Technical Glass Solutions GmbH

New kits improve upon well-established ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and improved uniformity of coverage depth for Illumina® and Oxford Nanopore Technologies® next generation sequencing (NGS) platforms IPSWICH, Mass — New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols for multiplexed amplicon-based sequencing of viral RNA: NEBNext® ARTIC SARS-CoV-2 [...]

Borosilicate Glass Microplates Improve Imaging Sensitivity

Porvair Sciences new Krystal™ Glass Bottom microplate with Schott D 263® M technology provides unmatched performance for whole-plate CCD imaging and laser detection applications. Krystal™ Glass Bottom plates combine the advantageous optical properties of glass, low background and low birefringence, with the versatility of a microplate.  Constructed in ultra-pure grade borosilicate glass – the new D 263® M, Krystal™ [...]

Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link

New Technology Provides Waters’ Empower Chromatography Data System Users with the Ability to Share and Analyze Lab Instrument Data MILFORD, Mass. --  Waters Corporation (NYSE:WAT) today announced it has entered a reseller agreement with TetraScience, a cloud technology innovator powering transformational changes in life sciences R&D. Through the partnership, Waters will now offer its customers [...]

Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

KANSAS CITY, Mo. and MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children’s Mercy Kansas City, one of the nation’s top pediatric medical centers, has increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add [...]

Twist Bioscience Launches Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies

-- Studying Methylation Patterns Provides Unique Insight into Disease Pathology -- -- System Improves Accuracy of Results, Allows Capture of Customized Genes of Interest, Operational Efficiency -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today [...]

SARCURA and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation, tackling manufacturing challenges of cell and gene therapies.

Collaboration between Sarcura and imec aims to develop a silicon photonics-based cytometry solution allowing real-time process control and manipulation of cells. Klosterneuburg (Austria) and Leuven (Belgium) - Sarcura GmbH, an Austrian early-stage technology startup, today announced that it has entered a collaboration with imec, a world-leading research and innovation hub in nanoelectronics and digital technologies to [...]

Yokogawa and ICQ Consultants Enter into Partnership Agreement for Biopharmaceutical Business

- Alliance enables support for bioreactor systems and related products in the United States - Yokogawa Electric Corporation Integrated Commissioning and Qualification Consultants, Corp. TOKYO, Japan and SOUTHBOROUGH, MA, USA -- Yokogawa Electric Corporation (TOKYO: 6841) (Yokogawa) and Integrated Commissioning and Qualification Consultants, Corp. (ICQ Consultants) of Southborough announce that they have entered into a [...]

QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia

Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions First-in-class next generation sequencing (NGS) assay designed for use on Illumina NextSeq™ 550Dx PLYMOUTH MEETING, PA., USA, and GERMANTOWN, MD., USA, and HILDEN, Germany – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an [...]

Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data

Project Underscores Growing Importance of Efficient Genomic Data Management, Visibility and Retrieval BOSTON –  Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. (NYSE: PFE) in the development of a data management and collaboration solution for the biopharmaceutical company’s single-cell ribonucleic acid (RNA) sequencing (scRNASeq) data. The Seven Bridges Platform is a cloud-based [...]

Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI’s Ultra Shear Technology

Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages SOUTH EASTON, Mass. --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the [...]

Access IBO on Knowledge Center